Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Moderate Hepatic Impairment × capivasertib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Triple Negative Breast Neoplasms 3 Disease Progression 2 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Moderate Hepatic Impairment 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia 1 Healthy Participants 1 Exanthema 1 Diarrhea 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07343960 2026-02-24

A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment

AstraZeneca

Phase 1 Recruiting

Moderate Hepatic Impairment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡